T. Rowe Price Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4B | Sell |
|
|||||
|
2025
Q1 | $1.19B | Buy |
|
|||||
|
2024
Q4 | $1.03B | Buy |
|
|||||
|
2024
Q3 | $863M | Sell |
|
|||||
|
2024
Q2 | $766M | Buy |
|
|||||
|
2024
Q1 | $429M | Sell |
|
|||||
|
2023
Q4 | $656M | Buy |
|
|||||
|
2023
Q3 | $602M | Buy |
|
|||||
|
2023
Q2 | $615M | Buy |
|
|||||
|
2023
Q1 | $607M | Sell |
|
|||||
|
2022
Q4 | $761M | Buy |
|
|||||
|
2022
Q3 | $639M | Buy |
|